(Q38177673)

30 August 2017

Suppressors of cytokine signaling (SOCS) and type 2 diabetes (English)

1 reference

30 August 2017

1 reference

Xiaotao Feng

1

1 reference

30 August 2017

Hongzhen Tang

series ordinal

2

1 reference

30 August 2017

Jing Leng

series ordinal

3

1 reference

30 August 2017

Qiuyan Jiang

series ordinal

4

1 reference

30 August 2017

12 January 2014

1 reference

Molecular Biology Reports

30 August 2017

1 reference

30 August 2017

41

1 reference

30 August 2017

4

1 reference

30 August 2017

2265-2274

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-014-3079-8

30 August 2017

0 references

cites work

Prevalence of diabetes among men and women in China

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

A new protein containing an SH2 domain that inhibits JAK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

LPS-induced release of IL-6 from glia modulates production of IL-1β in a JAK2-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

A family of cytokine-inducible inhibitors of signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Twenty proteins containing a C-terminal SOCS box form five structural classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

In vitro ubiquitination of cytokine signaling components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

The SOCS box-adapting proteins for ubiquitination and proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Predictors of the early impairment of renal disease in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

The N-terminal domains of SOCS proteins: a conserved region in the disordered N-termini of SOCS4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Insulin Induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 Skeletal Muscle Cells Is Mediated by Stat5*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

SOCS-3 is an insulin-induced negative regulator of insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Effect of opioid mu-receptors activation on insulin signals damaged by tumor necrosis factor alpha in myoblast C2C12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Novel link between inflammation and impaired glucose transport during equine insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Insulin receptor and IRS-1 co-immunoprecipitation with SOCS-3, and IKKα/β phosphorylation are increased in obese Zucker rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Regulation of SOCS-3 expression by leptin and its co-localization with insulin receptor in rat skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Role of neonatal hyperleptinaemia on serum adiponectin and suppressor of cytokine signalling-3 expression in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Hypothalamic resistin induces hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Activation of SOCS-3 by resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Effects of SOCS 1/3 gene silencing on the expression of C/EBPα and PPARγ during differentiation and maturation of rat preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Common variants in SOCS7 gene predict obesity, disturbances in lipid metabolism and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

No non-redundant function of suppressor of cytokine signaling 2 in insulin producing β-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Regulation of pancreatic beta-cell mass and proliferation by SOCS-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Proinflammatory cytokines induce NF-κB-Dependent/NO-independent chemokine gene expression in MIN6 β cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

SOCS-1 protein prevents Janus Kinase/STAT-dependent inhibition of beta cell insulin gene transcription and secretion in response to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-alpha induced apoptosis and signalling in beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

IL-1beta-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signaling-1 inhibits caspase activation and protects from cytokine-induced beta cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signaling 1 inhibits apoptosis of islet grafts through caspase 3 and apoptosis-inducing factor pathways in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Ciliary neurotrophic factor (CNTF) signals through STAT3-SOCS3 pathway and protects rat pancreatic islets from cytokine-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-A(y) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Thiazolidinediones and Heart Failure: A teleo-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Evaluating insulin secretagogues in a humanized mouse model with functional human islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Exenatide exerts a potent antiinflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Guggulsterone, a plant sterol, inhibits NF-kappaB activation and protects pancreatic beta cells from cytokine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

JANEX-1, a JAK3 inhibitor, protects pancreatic islets from cytokine toxicity through downregulation of NF-kappaB activation and the JAK/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

The traditional herbal medicine saireito exerts its inhibitory effect on murine oxazolone-induced colitis via the induction of Th1-polarized immune responses in the mucosal immune system of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Improving insulin resistance with traditional Chinese medicine in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3079-8

Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway

21 January 2018

1 reference

12 December 2020

[Effect of different intensities of electroacupuncture stimulation on expression of SOCS-3 and PPAR-gamma mRNA in adipose tissues of obesity rats].

1 reference

12 December 2020

Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study

1 reference

12 December 2020

The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells

1 reference

12 December 2020

Anti-inflammatory properties of exenatide in human pancreatic islets

1 reference

12 December 2020

Pollen Typhae total flavone improves insulin-induced glucose uptake through the β-arrestin-2-mediated signaling in C2C12 myotubes

1 reference

12 December 2020

Cbl, IRS-1, and IRS-2 mediate effects of rosiglitazone on PI3K, PKC-lambda, and glucose transport in 3T3/L1 adipocytes

1 reference

12 December 2020

[Effects of Huatan Tongluo Granule on SOCS-3 and TNF-alpha expressions in patients with acute cerebral infarction]

1 reference

12 December 2020

SOCS3 inhibits insulin signaling in porcine primary adipocytes

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1007/S11010-010-0558-7

Identifiers

DOI

10.1007/S11033-014-3079-8

1 reference

Dimensions Publication ID

30 August 2017

0 references

1 reference